Neri Antonino

Tenured Associate Professor
SSD
MED/15 - BLOOD DISEASES
Competition sector
06/D3 - BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY
Academic Senate member

Contacts

Workplace

Via Francesco Sforza, 35 - Ospedale Maggiore Policlinico - Pad. Marcora
20122 MILANO (MI)

Office phone number
02503 20420
Additional phone numbers
025503 3327
University email address
Teaching - Programme courses

Bachelors and masters

Postgraduate programmes

A.Y. 2019/2020
A.y. 2018/2019
Advanced course
Postgraduate Schools - Medicine, Healthcare, Dental Medicine
Research

Publications

Publications
  • Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases / F. Morabito, G. Tripepi, G. Del Poeta, F.R. Mauro, G. Reda, P. Sportoletti, L. Laurenti, M. Coscia, Y. Herishanu, S. Bossio, M. Varettoni, R. Murru, A. Chiarenza, A. Visentin, A. Condoluci, R. Moia, D. Pietrasanta, G. Loseto, U. Consoli, I. Scortechini, F.M. Rossi, A. Zucchetto, H. Al-Janazreh, E. Vigna, E.A. Martino, F. Mendicino, R. Cassin, G. D'Arrigo, S. Galimberti, A. Rago, I. Angeletti, A. Biagi, I. Del Giudice, R. Bomben, A. Neri, G. Fronza, P. Monti, P. Menichini, G. Cutrona, O. Jaksic, D. Rossi, F. Di Raimondo, A. Cuneo, G. Gaidano, A. Polliack, L. Trentin, R. Foa, M. Ferrarini, V. Gattei, M. Gentile. - In: EUROPEAN JOURNAL OF HAEMATOLOGY. - ISSN 0902-4441. - (2021 Jan 28). [Epub ahead of print]
  • Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair? / P. Menichini, P. Monti, A. Speciale, G. Cutrona, S. Matis, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza. - In: CELLS. - ISSN 2073-4409. - 10:1(2021 Jan 07).
  • What Is New in the Treatment of Smoldering Multiple Myeloma? / N. Bolli, N. Sgherza, P. Curci, R. Rizzi, V. Strafella, M. Delia, V. Pier Gagliardi, A. Neri, L. Baldini, F. Albano, P. Musto. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 10:3(2021), p. 421.
  • Halting the FGF/FGFR axis leads to anti-tumor activity in Waldenström's Macroglobulinemia by silencing MYD88 / A. Sacco, C. Federico, A. Giacomini, C. Caprio, F. Maccarinelli, K. Todoerti, V. Favasuli, A. Anastasia, M. Motta, D. Russo, G. Rossi, N. Bozza, R. Castelli, A. Neri, R. Ronca, C. Cattaneo, A. Tucci, M. Mor, M. Presta, A.M. Roccaro. - In: BLOOD. - ISSN 0006-4971. - (2020 Nov 16). [Epub ahead of print]
  • Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter? / P. Monti, P. Menichini, A. Speciale, G. Cutrona, F. Fais, E. Taiana, A. Neri, R. Bomben, M. Gentile, V. Gattei, M. Ferrarini, F. Morabito, G. Fronza. - In: FRONTIERS IN ONCOLOGY. - ISSN 2234-943X. - 10(2020 Oct 28).